Vaccine News and Research

Latest Vaccine News and Research

Antiviral activity assessment of remdesivir against 10 current and former SARS-CoV-2 variant clinical isolates

A new study published demonstrated the in vitro potencies of RDV and GS-441524 through PRA, and nucleoprotein ELISA against SARS-CoV-2 and other VOC/VOIs isolates with specific substitutions in Nsp12.

15 Feb 2022

Medical boards pressured to let it slide when doctors spread covid misinformation

Tennessee's Board of Medical Examiners unanimously adopted in September a statement that said doctors spreading covid misinformation — such as suggesting that vaccines contain microchips — could jeopardize their license to practice.

15 Feb 2022

Scientists identify potential reasons for COVID-19 vaccine hesitancy in US among individuals with chronic health conditions

A recent survey conducted on the adult population in the United States has identified the most common predictive reasons behind COVID-19 vaccine hesitancy.

15 Feb 2022

Novel glycation patterns help understand Omicron immune escape

A new study explores changes in the sugar structure of the SARS-CoV-2 Omicron variant, which may shed light on its immunologic escape and transmissibility characteristics.

15 Feb 2022

Estimates of COVID-19 hospitalization and ICU burden from existing severe acute respiratory infections surveillance

Researchers estimated SARS-CoV-2 hospitalization and ICU treatment during the first three waves of the COVID-19 pandemic.

15 Feb 2022

Producing more mRNA COVID vaccines could save 1.5M lives in low/middle-income countries

In a recent study posted to the medRxiv* preprint server, a team of researchers from the United States estimated the benefits of scaling up coronavirus disease 2019 (COVID-19) vaccination in the low- and lower-middle-income countries (LIC/LMICs) amid the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant using economic and epidemiological models linearized with public data of COVID-19 vaccinations and deaths.

15 Feb 2022

Researchers generate stable cell lines capable of producing various hepatitis B virus genotypes

A new study created stable cell lines capable of producing different genotypes of the hepatitis B virus (HBV), advancing understanding of each type's distinct virological features, treatment responses, and infectivity that could lead to new therapies against a virus infecting humans as far back as 4,500 years ago.

15 Feb 2022

Antiviral potential of N-acylethanolamine acid amide hydrolase against SARS-CoV-2 and Zika virus

A recent study posted to the bioRxiv* pre-print server investigated the antiviral potential of N-acylethanolamine acid amidase (NAAA) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the Zika virus (ZIKV).

14 Feb 2022

How many COVID cases have been prevented by vaccination in California?

A recent pre-print research paper posted to the medRxiv* server estimated the number of coronavirus disease 2019 (COVID-19) cases prevented due to the COVID-19 vaccines administered in California.

14 Feb 2022

Real-world data on efficacy and safety of COVID vaccines in Canada

In a recent study posted to the medRxiv* preprint server, researchers evaluated the efficacy and safety of the coronavirus disease 2019 (COVID-19) vaccines in young and elderly cohorts from Canada.

14 Feb 2022

First survey on Omicron BA.2 in France

In a recent study posted to the medRxiv* preprint server, researchers described the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 21L/BA.2 Omicron variant in south-eastern France.

14 Feb 2022

Study finds Pfizer-BioNTech COVID vaccine doesn't increase pregnancy risk

A new JAMA Network study describes the effects of maternal COVID-19 vaccination on pregnancy outcomes and infant health.

14 Feb 2022

Study analyzes antigenic properties of SARS-CoV-2 Omicron sublineages

A new study elucidated the antigenic properties of the sublineages of the severe acute respiratory syndrome coronavirus-2 Omicron variant.

14 Feb 2022

Study explores factors influencing countries with high rates of COVID-19 vaccine acceptance

A new study investigated the various factors affecting the acceptance rate and trust in SARS-CoV-2 vaccines in countries with high rates of vaccination.

14 Feb 2022

Development of multivalent next-generation vaccine strategy against ancestral SARS-CoV-2 and emerging variants

A recent study demonstrated that intranasal (i.n.) delivery of COVID-19 vaccine in murine models elicits greater immune responses against the wildtype SARS-CoV-2 and its variants.

14 Feb 2022

3 doses of Pfizer–Biontech COVID-19 vaccine offer more benefits than 2 doses

A Kaiser Permanente study published Feb. 14, 2022, in The Lancet Regional Health – Americas found that one month after a third dose, the Pfizer-BioNTech COVID-19 vaccine effectiveness is higher for preventing infection and hospitalization than 2 doses of the vaccine after 1 month.

14 Feb 2022

Vaccine News and Research

Latest Vaccine News and Research

Antiviral activity assessment of remdesivir against 10 current and former SARS-CoV-2 variant clinical isolates

Medical boards pressured to let it slide when doctors spread covid misinformation

Scientists identify potential reasons for COVID-19 vaccine hesitancy in US among individuals with chronic health conditions

Novel glycation patterns help understand Omicron immune escape

Estimates of COVID-19 hospitalization and ICU burden from existing severe acute respiratory infections surveillance

Producing more mRNA COVID vaccines could save 1.5M lives in low/middle-income countries

Researchers generate stable cell lines capable of producing various hepatitis B virus genotypes

Antiviral potential of N-acylethanolamine acid amide hydrolase against SARS-CoV-2 and Zika virus

How many COVID cases have been prevented by vaccination in California?

Real-world data on efficacy and safety of COVID vaccines in Canada

First survey on Omicron BA.2 in France

Study finds Pfizer-BioNTech COVID vaccine doesn't increase pregnancy risk

Study analyzes antigenic properties of SARS-CoV-2 Omicron sublineages

Study explores factors influencing countries with high rates of COVID-19 vaccine acceptance

Development of multivalent next-generation vaccine strategy against ancestral SARS-CoV-2 and emerging variants

3 doses of Pfizer–Biontech COVID-19 vaccine offer more benefits than 2 doses

Variations in the neutralization of SARS-CoV-2 variants in vaccinated mice and primates

Study describes a β-CoV spike protein target for protective antibodies that may facilitate pan-β-CoV vaccine development

Study explores the gut microbiome of COVID-19 patients

Differences in infection with Omicron or Delta SARS-CoV-2 variants among vaccinated population from the UK

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in